You're currently viewing OncGenius as a guest. To save your results, create an account or log in.
Advertisement
Leukemia
Leukemia
Leukemia
Vitamin D Levels in Patients With Leukemia Undergoing Stem Cell Transplant
Leukemia
CAR T-Cell Therapy for Patients With CLL/SLL: TRANSCEND CLL 004
Leukemia
Real-World Genomic Testing and Treatment Patterns for Adult Patients Newly Diagnosed With Leukemia
Leukemia
Survival and Prognostic Factors of Adults With Acute Leukemia Living in Uganda
Leukemia
Leukemia
Tailoring Treatment for Children With IKZF1-Deleted Acute Lymphocytic Leukemia
Leukemia
Pirtobrutinib in Pretreated Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Leukemia
Age-Based Inequality in Molecular Monitoring of Chronic Myeloid Leukemia
Leukemia
Impact of MRD Status on Survival Outcomes After Fixed-Duration Therapy in Patients With CLL
Leukemia
ASCO 2023: Patient Outcomes Following Brexucabtagene Autoleucel for Relapsed/Refractory B-Cell ALL
Leukemia
Leukemia
ASCO 2023: International Cooperation and Pediatric Leukemia Outcomes
Leukemia
NCCN Guidelines: Acute Myeloid Leukemia, Version 3.2023, Focus on BPDCN
Leukemia
Blinatumomab Plus Interfant-06 Chemotherapy in Infants With KMT2A-Rearranged ALL
Leukemia
Poverty’s Impact on Outcomes in Pediatric Acute Lymphoblastic Leukemia
Leukemia
Leukemia
Determining Risk of Relapse After Bone Marrow Transplant Among Patients With AML
Leukemia
Ethnic Disparities in Pediatric Leukemia Survival and U.S./Mexico Border Residence
Leukemia
Is Childhood Leukemia Linked to Maternal Infection During Pregnancy?
Leukemia
Leukemia
Ponatinib vs Imatinib for Newly Diagnosed Patients With Ph-Positive ALL
Leukemia
Food Insecurity and Receipt of SNAP Benefits Among Pediatric Patients With ALL
Leukemia
ASH 2022: Zanubrutinib in Patients With Relapsed or Refractory CLL/SLL
Leukemia
ASH 2022: Efficacy of Triplet Combinations in Acute Myeloid Leukemia
Leukemia
Leukemia
ASH 2022: Impact of Momelotinib on Patient-Reported Quality of Life for Patients With Myelofibrosis
Leukemia
Real-World Cost of Pediatric ALL Care Among Commercially Insured Patients
Leukemia
Leukemia
Dosing of Tisagenlecleucel Among Pediatric Patients With Leukemia and Improved Outcomes
Leukemia
Acute Leukemia Survival Outcomes Over Time in South Australia
Leukemia
Phase III Trial Evaluates Quizartinib for FLT3-ITD–Positive AML
Leukemia
Zanubrutinib for Untreated Patients With CLL/SLL: SEQUOIA Trial
Leukemia
Leukemia
ASCO 2022: Asciminib vs Bosutinib in Pretreated Patients With CML in Chronic Phase
Leukemia
Leukemia
ASCO 2022: Crenolanib Combined With Chemotherapy in Newly Diagnosed FLT3-Mutant AML
Leukemia
ASCO 2022: New Data on IDH2-Mutant Alleles and Endasidenib in AML
Leukemia
ASCO 2022: Measurable Residual Disease Testing as Prognostic Tool in Acute Myeloid Leukemia
Leukemia
Addition of Ivosidenib to Azacitidine in Newly Diagnosed IDH1-Mutated AML
CategoriesView All Quizzes
Tumor Type
- Breast Cancer
- Gastrointestinal Cancers
- Genitourinary Cancers
- Gynecologic Cancers
- Head & Neck/Thyroid Cancer
- Leukemia
- Lung Cancer
- Lymphoma
- Melanoma
- Multiple Myeloma
Additional Topics
Conference Coverage
- 2021 ASH Annual Meeting & Exposition
- 2021 San Antonio Breast Cancer Symposium
- 2022 ASCO Annual Meeting
- 2022 ASCO Gastrointestinal Cancers Symposium
- 2022 ASCO Genitourinary Cancers Symposium
- 2022 ASCO Quality Care Symposium
- 2022 ASH Annual Meeting and Exposition
- 2022 Multidisciplinary Head and Neck Cancers Symposium
- 2022 San Antonio Breast Cancer Symposium
- 2023 ASCO Annual Meeting
- 2023 ASCO Gastrointestinal Cancers Symposium
- 2023 ASCO Genitourinary Cancers Symposium
- 2023 ASH Annual Meeting and Exposition
- 2023 San Antonio Breast Cancer Symposium
- 2024 ASCO Annual Meeting
- 2024 ASCO Gastrointestinal Cancers Symposium
- 2024 ASCO Genitourinary Cancers Symposium
- AACR Annual Meeting 2022
- AACR Annual Meeting 2023
- ASTRO Annual Meeting 2022
- ESMO Congress 2022
- ESMO Congress 2023
- ESMO Congress 2024